The findings that PTX3 promotes long‐term recovery of cerebral blood flow, angiogenesis, and neuronal viability after cerebral ischemia suggest the potential for PTX3 as a promising therapeutic target of clinical relevance (Rajkovic et al., 2018). Here, PTX3 is linked to Cerebral ischemia.